UCL Discovery Stage
UCL home » Library Services » Electronic resources » UCL Discovery Stage

Cost effectiveness of testing HIV infected individuals for TB in a low TB/HIV setting

Capocci, SJ; Sewell, J; Smith, C; Cropley, I; Bhagani, S; Solamalai, A; Morris, S; ... Lipman, MCI; + view all (2020) Cost effectiveness of testing HIV infected individuals for TB in a low TB/HIV setting. Journal of Infection , 81 (2) pp. 289-296. 10.1016/j.jinf.2020.05.055. Green open access

[thumbnail of Lipman_Cost effectiveness TB testing 15 May 2020.pdf]
Preview
Text
Lipman_Cost effectiveness TB testing 15 May 2020.pdf - Accepted Version

Download (488kB) | Preview
[thumbnail of Web appendix 15May2020.pdf]
Preview
Text
Web appendix 15May2020.pdf - Accepted Version

Download (544kB) | Preview
[thumbnail of Figure 2 CEAC 10May2020 as pdf.pdf]
Preview
Text
Figure 2 CEAC 10May2020 as pdf.pdf - Accepted Version

Download (177kB) | Preview
[thumbnail of Fig 1 Cohort 10 May2020 as pdf.pdf]
Preview
Text
Fig 1 Cohort 10 May2020 as pdf.pdf - Accepted Version

Download (23kB) | Preview

Abstract

Objectives : Guidelines recommend routine testing for latent TB infection (LTBI) in people living with HIV. However there are few cost-effectiveness studies to justify this in contemporary high resource, low TB/HIV incidence settings. We sought to assess the uptake, yield and cost-effectiveness of testing for latent and active TB. Methods : Adults attending an ambulatory HIV clinic in London, UK were prospectively recruited by stratified selection and tested for TB infection using symptom questionnaires, chest radiograph (CXR), tuberculin skin test (TST), T-Spot.TB and induced sputum. From this, 30 testing strategies were compared in a cost-effectiveness model including probabilistic sensitivity analysis using Monte Carlo simulation. Results : 219 subjects were assessed; 95% were using antiretroviral therapy (ART). Smear negative, culture positive TB was present in 0.9% asymptomatic subjects, LTBI in 9%. Only strategies testing those from subSaharan Africa with a TST or interferon gamma release assay (IGRA) with or without CXR, or testing those from countries with a TB incidence of >40/100,000 with TST alone were cost-effective using a £30,000/QALY threshold. Conclusions : Cost-effectiveness analysis in an adult HIV cohort with high ART usage suggests there is limited benefit beyond routine testing for latent TB in people from high and possibly medium TB incidence settings.

Type: Article
Title: Cost effectiveness of testing HIV infected individuals for TB in a low TB/HIV setting
Open access status: An open access version is available from UCL Discovery
DOI: 10.1016/j.jinf.2020.05.055
Publisher version: https://doi.org/10.1016/j.jinf.2020.05.055
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
Keywords: Tuberculosis, HIV infection, Costs and Cost analysis, Adult, Screening
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Infection and Immunity
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Respiratory Medicine
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute for Global Health
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute for Global Health > Infection and Population Health
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Epidemiology and Health
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Epidemiology and Health > Applied Health Research
URI: https://discovery-pp.ucl.ac.uk/id/eprint/10098911
Downloads since deposit
22,648Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item